Cytoplasmic calcium mediates oxidative damage in an excitotoxic/energetic deficit synergic model in rats

European Journal of Neuroscience

Volumn 27, Issue 5, 2008, Pages 1075-1085

  Pérez De La Cruz, Verónica ^a   Konigsberg, Mina ^a   Pedraza Chaverri, José ^b   Herrera Mundo, Nieves ^a   Díaz Muñoz, Mauricio ^c   Morán, Julio ^d   Fortoul Van Der Goes, Teresa ^d   Rondán Zárate, Adrián ^d   Maldonado, Perla D ^e   Ali, Syed F ^f   Santamaría, Abel ^a,f  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^b DEPARTAMENTO DE QUÍMICA   (Mexico)

^c Departamento de Biología

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^e CENTRO DE FÍSICA APLICADA Y TECNOLOGÍA AVANZADA   (Mexico)

^f NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

3 nitropropionic acid; Cytoplasmic Ca2+; Lipid peroxidation; Quinolinate; Synergism

Indexed keywords

3 NITROPROPIONIC ACID; 5,10,15,20 TETRAKIS(4 SULFONATOPHENYL)PORPHYRINATO IRON; CALCIUM; DIZOCILPINE; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID ACETOXYMETHYL ESTER; IRON PORPHYRINATE; LEVACECARNINE; PEROXYNITRITE; PORPHYRIN DERIVATIVE; QUINOLINIC ACID; S ALLYLCYSTEINE; THIOBARBITURIC ACID; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOPLASM; DRUG EFFECT; ENERGY RESOURCE; EXCITOTOXICITY; MALE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; POSTSYNAPTIC MEMBRANE; PRIORITY JOURNAL; RAT; SYNAPTOSOME;

EID: 41149148819     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2008.06088.x     Document Type: Article

References (59)

1. Abdel-Hamid, K.M. Tymianski, M. (1997) Mechanisms and effects of intracellular calcium buffering on neuronal survival in organotypic hippocampal cultures exposed to anoxia/aglycemia or to excitotoxins. J. Neurosci., 17, 3538 3553.
2. Albin, R.L. Greenamyre, J.T. (1992) Alternative excitotoxic hypotheses. Neurology, 42, 733 738.
3. Alexi, T., Hughes, P.E., Faull, R.L. Williams, C.E. (1998) 3-Nitroptopionic acid's lethal triplet: cooperative pathways of neurodegeneration. Neuroreport, 9, 57 64.
4. Bahn, A., Ljubojevic, M., Lorenz, H., Schultz, C., Ghebremedhin, E., Ugele, B., Sabolic, I., Burckhardt, G. Hagos, Y. (2005) Murine renal organic anion transporters mOAT1 and mOAT3 facilitate the transport of neuroactive tryptophan metabolites. Am. J. Physiol. Cell. Physiol., 289, C1075 C1084.
5. Bazzett, T.J., Falik, R.C., Becker, J.B. Albin, R.L. (1996) Synergistic effects of chronic exposure to subthreshold concentrations of quinolinic acid and malonate in the rat striatum. Brain. Res., 718, 228 232.
6. Beal, M.F. (1992) Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann. Neurol., 31, 19 30.
7. Beal, M.F. (1995) Aging, energy, and oxidative stress in neurodegenerative diseases. Ann. Neurol., 38, 357 366.
8. Beal, M.F., Hyman, B.T. Koroshetz, W. (1993) Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? Trends Neurosci., 16, 125 131.
9. Beal, M.F., Kowall, N.W., Ellison, D.W., Mazurek, M.F., Swartz, K.J. Martin, J.B. (1986) Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature, 321, 68 71.
10. Behan, W.M., McDonald, M., Darlington, L.G. Stone, T.W. (1999) Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl. Br. J. Pharmacol., 128, 1754 1760.
11. Behrens, M.I., Koh, J., Canzoniero, L.M., Sensi, S.L., Csernansky, C.A. Choi, D.W. (1995) 3-Nitropropionic acid induces apoptosis in cultured striatal and cortical neurons. Neuroreport, 6, 545 548.
12. Bordelon, Y.M., Chesselet, M.F., Nelson, D., Welsh, F. Erecińska, M. (1997) Energetic dysfunction in quinolinic acid-lesioned rat striatum. J. Neurochem., 69, 1629 1639.
13. Brouillet, E., Conde, F., Beal, M.F. Hantraye, P. (1999) Replicating Huntington's disease phenotype in experimental animals. Prog. Neurobiol., 59, 427 468.
14. Carafoli, E., Tiozzo, R., Lugli, G., Crovetti, F. Kratzing, C. (1974) The release of calcium from heart mitochondria by sodium. J. Mol. Cell. Cardiol., 6, 361 371.
15. Coles, C.J., Edmondson, D.E. Singer, T.P. (1979) Inactivation of succinate dehydrogenase by 3-nitropropionate. J. Biol. Chem., 254, 5161 5167.
16. Dodd, P.R., Hardy, J.A., Oakley, A.E., Edwarson, J.A., Perry, E.K. Delaunoy, J.P. (1981) A rapid method for preparing synaptosomes: comparison, with alternative procedures. Brain Res., 226, 107 118.
17. 2+ cycling. Exp. Physiol., 88, 91 97.
18. García, A. Massieu, L. (2003) Glutamate uptake inhibitor 1-trans-pyrrolidine 2,4-dicarboxylate becomes neurotoxic in the presence of subthreshold concentrations of mitochondrial toxin 3-nitropropionate: involvement of mitochondrial reducing activity and ATP production. J. Neurosci. Res., 74, 956 966.
19. Goda, K., Kishimoto, H., Shimizu, S., Hamane, Y. Ueda, M. (1996) Quinolinic acid and active oxygens. Possible contribution of active oxygens during cell death in the brain. Adv. Exp. Med. Biol., 398, 247 254.
20. Greene, J.G. Greenamyre, J.T. (1995) Exacerbation of NMDA, AMPA, and L-glutamate excitotoxicity by the succinate dehydrogenase inhibitor malonate. J. Neurochem., 64, 2332 2338.
21. Greene, J.G. Greenamyre, J.T. (1996) Manipulation of membrane potential modulates malonate-induced striatal excitotoxicity in vivo. J. Neurochem., 66, 637 643.
22. Guidetti, P., Luthi-Carter, R.E., Augood, S.J. Schwarcz, R. (2004) Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease. Neurobiol. Dis., 17, 455 461.
23. Guillemin, G.J., Brew, B.J., Noonan, C.E., Takikawa, O. Cullen, K.M. (2005) Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampus. Neuropathol. Appl. Neurobiol., 31, 395 404.
24. Hamilton, B.F. Gould, D.H. (1987) Nature and distribution of brain lesions in rats intoxicated with 3-nitropropionic acid: a type of hypoxic (energy deficient) brain damage. Acta Neuropathol., 72, 286 297.
25. Heyes, M.P., Achim, C.L., Wiley, C.A., Major, E.O., Saito, K. Markey, S.P. (1996) Human microglia convert L-tryptophan into the neurotoxin quinolinic acid. Biochem. J., 320, 595 597.
26. 2+ entry during NMDA receptor activation. FASEB J., 20, 1021 1023.
27. La Fontaine, M.A., Geddes, J.W., Banks, A. Butterfield, D.A. (2000) 3-Nitropropionic acid induced in vivo protein oxidation in striatal and cortical synaptosomes: insights into Huntington's disease. Brain Res., 858, 356 362.
28. Lafon-Cazal, M., Pietri, S., Culcasi, M. Bockaert, J. (1993) NMDA-dependent superoxide production and neurotoxicity. Nature, 364, 535 537.
29. Leipnitz, G., Schumacher, C., Scussiato, K., Dalcin, K.B., Wannmacher, C.M., Wyse, A.T., Dutra-Filho, C.S., Wajner, M. Latini, A. (2005) Quinolinic acid reduces the antioxidant defenses in cerebral cortex of young rats. Int. J. Dev. Neurosci., 23, 695 701.
30. Lowe, D.A., Richardson, N.P., Taylor, P. Donatsch, P. (1976) Increasing intracellular sodium triggers calcium release from bound pools. Nature, 260, 337 338.
31. Martin, R.L., Lloyd, H.E. Cowan, A.I. (1994) The early events of oxygen and glucose deprivation: Setting the scene for neuronal death? Trends Neurosci., 17, 251 257.
32. Massieu, L., Morales-Villagràn, A. Tapia, R. (1995) Accumulation of extracellular glutamate by inhibition of its uptake is not sufficient for inducing neuronal damage: an in vivo microdialysis study. J. Neurochem., 64, 2262 2272.
33. Muralikrishna Adibhatla, R. Hatcher, J.F. (2006) Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia. Free Radic. Biol. Med., 40, 376 387.
34. Muranon, L., Antoniotti, S. Lovisolo, D. (2004) Intracellular calcium signals and control of cell proliferation: how many mechanisms? J. Cell. Mol. Med., 8, 161 168.
35. Nakamura, T.A., Yamada, K., Hasegawa, T. Nabeshima, T. (1995) Possible involvement of nitric oxide in quinolinic acid-induced convulsion in mice. Pharmacol. Biochem. Behav., 51, 309 312.
36. 2+, ATP, mitochondrial membrane potential, and calpain activity on the mechanism of neuron death induced by 3-nitropropionic acid. Neurochem. Int., 43, 89 99.
37. Niesen, C., Charlton, M.P. Carlen, P.L. (1991) Postsynaptic and presynaptic effects of the calcium chelator BAPTA on synaptic transmission in rat hippocampal dentate granule neurons. Brain Res., 555, 319 325.
38. Noack, H., Lindenau, J., Rothe, F., Asayama, K. Wolf, G. (1998) Differential expression of superoxide dismutase isoforms in neural and glial compartments in the course of excitotoxically mediated degeneration: relation to oxidative and nitrergic stress. Glia, 23, 285 297.
39. Novelli, A., Reilly, J.A., Lysko, P.G. Henneberry, R.C. (1988) Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res., 451, 205 212.
40. Pang, Z. Geddes, J.W. (1997) Mechanisms of cell death induced by mitochondrial toxin 3-nitropropionic acid: acute excitotoxic necrosis and delayed apoptosis. J. Neurosci., 17, 3064 3073.
41. Pérez-De La Cruz, V., Gonzalez-Cortes, C., Galvan-Arzate, S., Medina-Campos, O.N., Pérez-Severiano, F., Ali, S.F., Pedraza-Chaverri, J. Santamaría, A. (2005) Excitotoxic brain damage involves early peroxynitrite formation in a model of Huntington's disease in rats: protective role of iron porphyrinate 5,10,15,20-tetrakis (4-sulfonatophenyl) porphyrinate iron (III). Neuroscience, 135, 463 474.
42. Pérez-De La Cruz, V., Gonzalez-Cortes, C., Pedraza-Chaverri, J., Maldonado, P.D., Andres-Martinez, L. Santamaría, A. (2006) Protective effect of S-allylcysteine on 3-nitropropionic acid-induced lipid peroxidation and mitochondrial dysfunction in rat brain synaptosomes. Brain Res. Bull., 68, 379 383.
43. Rami, A., Ferger, D. Krieglstein, J. (1997) Blockade of calpain proteolytic activity rescues neurons from glutamate excitotoxicity. Neurosci. Res., 27, 93 97.
44. Ribeiro, C.A., Grando, V., Dutra Filho, C.S., Wannmacher, C.M. Wajner, M. (2006) Evidence that quinolinic acid severely impairs energy metabolism through activation of NMDA receptors in striatum from developing rats. J. Neurochem., 99, 1531 1542.
45. Ryu, J.K., Kim, S.U. McLarnon, J.G. (2004) Blockade of quinolinic acid-induced neurotoxicity by pyruvate is associated with inhibition of glial activation in a model of Hungtington's disease. Exp. Neurol., 187, 150 159.
46. Santamaría, D., Espinoza-Gonzalez, V., Rios, C. Santamaría, A. (1999) Nomega-nitro-L-arginine, a nitric oxide synthase inhibitor, antagonizes quinolinic acid-induced neurotoxicity and oxidative stress in rat striatal slices. Neurochem. Res., 24, 843 848.
47. Santamaría, A., Jimenez-Capdeville, M.E., Camacho, A., Rodríguez, E., Flores, A. Galvan-Arzate, S. (2001) In vivo hydroxyl radical formation after quinolinic acid infusion into rat corpus striatum. Neuroreport, 12, 2693 2696.
48. Santamaría, A. Rios, C. (1993) MK-801, an N-methyl-D-aspartate receptor antagonist, blocks quinolinic acid-induced lipid peroxidation in rat corpus striatum. Neurosci. Lett., 159, 51 54.
49. Santamaría, A., Salvatierra-Sanchez, R., Vazquez-Roman, B., Santiago-Lopez, D., Villeda-Hernandez, J., Galvan-Arzate, S., Jimenez-Capdeville, M.E. Ali, S.F. (2003) Protective effects of the antioxidant selenium on quinolinic acid-induced neurotoxicity in rats: in vitro and in vivo studies. J. Neurochem., 86, 479 488.
50. Sardar, A.M. Reynolds, G.P. (1995) Frontal cortex indoleamine-2-3- dioxygenase activity is increased in HIV-1 associated dementia. Neurosci. Lett., 187, 9 12.
51. Sardar, A.M., Bell, J.E. Reynolds, G.P. (1995) Increased concentrations of the neurotoxin 3-hydroxykynurenine in the frontal cortex of HIV-1-positive patients. J. Neurochem., 64, 932 935.
52. Sas, K., Robotka, H., Toldi, J. Vecsei, L. (2007) Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders. J. Neurol. Sci., 257, 221 239.
53. Schuck, P.F., Tonin, A., Da Costa Ferreira, G., Rosa, R.B., Latini, A., Balestro, F., Perry, M.L., Wannmacher, C.M., De Souza Wyse, A.T. Wajner, M. (2007) In vitro effect of quinolinic acid on energy metabolism in brain of young rats. Neurosci. Res., 57, 277 288.
54. Schwarcz, R. (1983) Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science, 219, 316 318.
55. Stípek, S., Stastny, F., Platenik, J., Crkovská, J. Zima, T. (1997) The effect of quinolinate on rat brain lipid peroxidation is dependent on iron. Neurochem. Int., 30, 233 237.
56. Stone, T.W. (1993) Neuropharmacology of quinolinic and kynurenic acids. Pharmacol. Rev., 45, 309 379.
57. Túnez, I., Montilla, P., Muñoz, M.C., Feijoo, M. Salcedo, M. (2004) Protective effect of melatonin on 3-nitropropionic acid-induced oxidative stress in synaptosomes in an animal model of Huntington's disease. J. Pineal Res., 37, 252 256.
58. Walsh, D.M., Klyubin, I., Fadeeva, J.V., Cullen, W.K., Anwyl, R., Wolfe, M.S., Rowan, M.J. Selkoe, D.J. (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature, 416, 535 539.
59. Zeevalk, G.D., Derr-Yellin, E. Nicklas, W.J. (1995) Relative vulnerability of dopamine and GABA neurons in mesencephalic culture to inhibition of succinate dehydrogenase by malonate and 3-nitropropionic acid and protection by NMDA receptor blockade. J. Pharmacol. Exp. Ther., 275, 1124 1130.